Vivimed Labs Profile
Key Indicators
- Authorised Capital ₹ 111.00 Cr
- Paid Up Capital ₹ 16.58 Cr
- Company Age 36 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 932.51 Cr
- Satisfied Charges ₹ 791.99 Cr
- Revenue Growth -19.38%
- Profit Growth -384.13%
- Ebitda -1941.40%
- Net Worth -70.85%
- Total Assets -26.08%
About Vivimed Labs
Vivimed Labs Limited (VLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 September 1988 and has a history of 36 years and four months. Its registered office is in Karnataka., Karnataka, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532660 and on the National Stock Exchange(NSE) under VIVIMEDLAB.
The Corporate was formerly known as Emgi Pharmaceuticals & Chemicals Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 111.00 Cr and a paid-up capital of Rs 16.58 Cr.
The company currently has active open charges totaling ₹932.51 Cr. The company has closed loans amounting to ₹791.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vivimed Labs Limited India is Kopparthi Yugandhar as COMPANY SECRETARY. Aparna Bidarkar, Manohar Varalwar, Subhash Varalwar, and Three other members serve as directors at the Company.
Company Details
-
Location
Karnataka., Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
L02411KA1988PLC009465
-
Company No.
009465
-
Stock Symbol
BSE : 532660 NSE : VIVIMEDLAB
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 1988
-
Date of AGM
13 Nov 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Listed
-
ROC Code
Roc Bangalore
Industry
What products or services does Vivimed Labs Limited offer?
Vivimed Labs Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Products, Industrial Dyes, Skin Care Cosmetics, Sun Protection Cream, Dermatology Treatment Services, Nasal Drops, Xylometazoline Nasal Drops, Medical Treatment Services, Dental Treatment Services.
Who are the key members and board of directors at Vivimed Labs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Varalwar
|
Managing Director | 09-Nov-1989 | Current |
|
Kopparthi Yugandhar
|
Company Secretary | 30-Oct-2012 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Aparna Bidarkar
|
Director | 14-Feb-2022 | Current |
|
Manohar Varalwar
|
Whole-Time Director | 10-Nov-1994 | Current |
|
Subhash Varalwar
|
Director | 09-Nov-1989 | Current |
|
Hari Jamalapuram
|
Director | 14-Feb-2020 | Current |
|
Sandeep Varalwar
|
Whole-Time Director | 23-Jan-2008 | Current |
Financial Performance of Vivimed Labs.
Vivimed Labs Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.38% decrease. The company also saw a substantial fall in profitability, with a 384.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 70.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivimed Labs?
In 2023, Vivimed Labs had a promoter holding of 20.94% and a public holding of 79.06%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uquifa India Private LimitedSantosh Varalwar is a mutual person
-
Lattice Projex Private LimitedAparna Bidarkar is a mutual person
-
B B R Projects Private Limited
Manohar Varalwar, Santosh Varalwar and 1 more are mutual person
-
Kreative Hosts Atria Private Limited
Manohar Varalwar and Santosh Varalwar are mutual person
-
Atri Pharma Research (India) Private Limited
Santosh Varalwar is a mutual person
-
Anand Eye Institute Private Limited
Santosh Varalwar is a mutual person
Charges (Loans)
₹932.51 Cr
₹791.99 Cr
Charges Breakdown by Lending Institutions
- Others : 474.62 Cr
- State Bank Of India : 310.57 Cr
- Allahabad Bank : 70.00 Cr
- International Finance Corporation : 62.50 Cr
- State Bank Of Hyderabad : 14.16 Cr
- Others : 0.66 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2020 | State Bank Of India | ₹232.00 Cr | Open |
| 29 Jul 2020 | State Bank Of India | ₹15.00 Cr | Open |
| 08 Nov 2017 | State Bank Of India | ₹4.50 Cr | Open |
| 02 Apr 2015 | Corporation Bank | ₹1.60 M | Open |
| 25 Sep 2014 | State Bank Of Hyderabad | ₹5.75 Cr | Open |
How Many Employees Work at Vivimed Labs?
Vivimed Labs has a workforce of 75 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivimed Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivimed Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
